Why I’m Deleting the NextDoor App

government mandate

My wife is a very blunt woman. So, last week, when she got into a battle with anti-vaccination neighbors on Facebook, I zoned out as best as I could when she started ranting about it. My three-year-old daughter caught COVID-19 in May. We don’t know what variant it was. But we do know that it knocked a healthy kid on her backside. She still has a ways to go to recover. No one should want this as a parent. I don’t understand how people gladly purchase Russian vodka at a store or gladly buy vitamins and supplements from renegade super factories in Mexico and China… But be asked to take a vaccine? Now you’re moving into World War 3 territory. 

I’m on my third shot now of Pfizer (NYSE:PFE) thanks to the latest dose for the immunosuppressed. I assure you that I don’t now have a penchant for centralized planning, giving the government more of my money, or voting for any person who walks the halls of Congress or the White House. The vaccine has done a good job at keeping me upright at the epicenter for months.

Can the Government Mandate Vaccines?

But now the real challenge comes. The Biden Administration is moving to create a mandate that would force all public sector employees to get the vaccine in the wake of the FDA’s approval of Pfizer’s shot. A neighbor on NextDoor hit the chat board hard on that one. “The government can’t make employees get a vaccine,” she wrote. Yes it can. And now there’s chatter about private sector firms forcing the same – and the possibility of a government mandate as well. 

I know, I know… it was the government that got everyone into this mess in the first place, and the solution to fixing problems is always more government if you’re a politician. But the government can do that as well. It might get tied up in the courts, but the 1905 Supreme Court case Jacobson v. Massachusetts, 197 U.S. 11 (1905) gives the government precedent to act on a mandate. Could it be challenged? Overturned? Maybe… but it would take a pretty steep hill and a lot of legal willingness to try.

What Could This Impact?

Whether the Biden Administration moves forward with this, it could have far-reaching implications. How would it impact infrastructure spending if certain centrist Democrats are worried about losing their seat in 2022? How will the market react to the fact that the Republicans might take the House back? What about tax policy? Or tax hikes? What about healthcare stocks?

Everything interlinks. Everything intertwines. For every action, there is a reaction. Already, people are drawing lines in the sand – neighbors against neighbors on NextDoor over masks and vaccines. If you think NextDoor is bad… Congress is this experience on drugs. No matter what happens, I’ll show you how to profit. This is good news for Pfizer, a company that Dr. Bauer covered this week. But there are more options in play. For now, let’s just take a step back and turn off the apps. I can’t take anymore of my neighbor feeding the local bobcats… let alone yelling at someone else over things they can’t control.

Garrett Baldwin
Garrett Baldwin
Garrett Baldwin joined Godesburg Financial Publishing as Chief U.S. Markets Analyst in early 2021. A Johns Hopkins-trained Economist, he’s worked with hedge funds, venture capital firms, angel investors, and economic advisors to the U.S. government. Baldwin specializes in market anomalies and alternative investments. He’s written extensively on momentum, value, insider buying, and other unique strategies that provide investors that elusive edge.
Garrett Baldwin
Garrett Baldwin
Garrett Baldwin joined Godesburg Financial Publishing as Chief U.S. Markets Analyst in early 2021. A Johns Hopkins-trained Economist, he’s worked with hedge funds, venture capital firms, angel investors, and economic advisors to the U.S. government. Baldwin specializes in market anomalies and alternative investments. He’s written extensively on momentum, value, insider buying, and other unique strategies that provide investors that elusive edge.

Related Articles

biontech share

BioNTech Share Favorably Valued

Today we are talking about the Mainz-based biotech company BioNTech (BNTX). Similar to HelloFresh, this “fallen angel” is well worth a look. COVID-19 Vaccine Brings

Read More »